Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases

Jun Ren1,2,3, Yaguang Bi4, James R Sowers5,6

  • 1Department of Cardiology and Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China. jren@uw.edu.

Nature Reviews. Cardiology
|February 23, 2021
PubMed

Insights

Cardiovascular diseases (CVDs) are linked to endoplasmic reticulum (ER) stress, where protein misfolding disrupts cell function. Targeting ER proteostasis offers potential new therapies for heart disease.

Area of Science:

  • Cardiovascular Science
  • Cellular Biology
  • Molecular Medicine

Background:

  • Cardiovascular diseases (CVDs) are a major global health burden, encompassing conditions like heart failure and stroke.
  • Many CVDs share underlying mechanisms, including impaired protein homeostasis (proteostasis) within the endoplasmic reticulum (ER).
  • The unfolded protein response (UPR) is a cellular pathway that manages ER proteostasis, crucial for cell function.

Purpose of the Study:

  • To review the dual role of the UPR and ER stress as both causes and consequences in cardiovascular disease pathogenesis.
  • To summarize recent advancements in understanding the UPR and ER stress in CVD.
  • To explore therapeutic strategies focused on restoring ER proteostasis for CVD treatment.

Main Methods:

  • Literature review of existing research on UPR, ER stress, and CVD.
  • Analysis of pathophysiological links between proteostasis disruption and cardiovascular dysfunction.
  • Synthesis of current knowledge on therapeutic interventions targeting ER pathways.

Main Results:

  • ER stress, characterized by unfolded or misfolded protein accumulation, is a common feature across various CVDs.
  • The UPR's adaptive capacity can be overwhelmed, leading to maladaptive responses, ER integrity loss, and apoptosis.
  • Chronic ER stress contributes to cellular defects that impair cardiovascular function.

Conclusions:

  • The UPR and ER stress play significant roles in the development and progression of cardiovascular diseases.
  • Understanding these pathways is critical for developing novel therapeutic approaches.
  • Restoring ER proteostasis presents a promising avenue for treating CVDs.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
6.4K
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
4.7K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
177
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.7K